Kadimastem (Israel) Market Value
| KDST Stock | ILA 1,189 14.00 1.19% |
| Symbol | Kadimastem |
Kadimastem 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kadimastem's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kadimastem.
| 11/22/2024 |
| 12/22/2024 |
If you would invest 0.00 in Kadimastem on November 22, 2024 and sell it all today you would earn a total of 0.00 from holding Kadimastem or generate 0.0% return on investment in Kadimastem over 30 days. Kadimastem is related to or competes with Kamada, Teva Pharmaceutical, Tower Semiconductor, Elbit Systems, and Opko Health. Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human ... More
Kadimastem Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kadimastem's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kadimastem upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.32 | |||
| Information Ratio | 0.176 | |||
| Maximum Drawdown | 44.32 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 12.2 |
Kadimastem Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kadimastem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kadimastem's standard deviation. In reality, there are many statistical measures that can use Kadimastem historical prices to predict the future Kadimastem's volatility.| Risk Adjusted Performance | 0.1516 | |||
| Jensen Alpha | 1.42 | |||
| Total Risk Alpha | 1.21 | |||
| Sortino Ratio | 0.2648 | |||
| Treynor Ratio | 6.02 |
Kadimastem Backtested Returns
Kadimastem is very steady given 3 months investment horizon. Kadimastem has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17% return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.56% are justified by taking the suggested risk. Use Kadimastem Mean Deviation of 4.93, risk adjusted performance of 0.1516, and Downside Deviation of 5.32 to evaluate company specific risk that cannot be diversified away. Kadimastem holds a performance score of 13 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.24, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kadimastem's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kadimastem is expected to be smaller as well. Use Kadimastem coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to analyze future returns on Kadimastem.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
Kadimastem has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Kadimastem time series from 22nd of November 2024 to 7th of December 2024 and 7th of December 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kadimastem price movement. The serial correlation of -0.71 indicates that around 71.0% of current Kadimastem price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 956.32 |
Kadimastem lagged returns against current returns
Autocorrelation, which is Kadimastem stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kadimastem's stock expected returns. We can calculate the autocorrelation of Kadimastem returns to help us make a trade decision. For example, suppose you find that Kadimastem has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kadimastem regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kadimastem stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kadimastem stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kadimastem stock over time.
Current vs Lagged Prices |
| Timeline |
Kadimastem Lagged Returns
When evaluating Kadimastem's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kadimastem stock have on its future price. Kadimastem autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kadimastem autocorrelation shows the relationship between Kadimastem stock current value and its past values and can show if there is a momentum factor associated with investing in Kadimastem.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kadimastem Stock
Kadimastem financial ratios help investors to determine whether Kadimastem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.